Johnson Chemical Pharmaceutical Works Co., Ltd. - Laporan Laba Rugi (TTM)

Johnson Chemical Pharmaceutical Works Co., Ltd.
TW ˙ TPEX
NT$ 73.20 ↑0.50 (0.69%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Johnson Chemical Pharmaceutical Works Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 445 424 412 413 408 411 416 434 460 495 533 572 593 607 621 616 618 611 595 583
Change (%) -4.67 -2.83 0.34 -1.21 0.75 1.12 4.25 6.05 7.53 7.75 7.25 3.75 2.29 2.38 -0.77 0.32 -1.12 -2.68 -2.05
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 243 232 228 233 233 240 242 258 271 290 312 331 349 362 374 372 371 363 352 347
Change (%) -4.61 -1.51 2.09 -0.14 2.92 1.08 6.36 5.42 6.93 7.54 6.08 5.36 3.78 3.30 -0.65 -0.06 -2.14 -3.27 -1.41
% of Revenue 54.64 54.68 55.42 56.38 57.00 58.22 58.19 59.37 59.01 58.68 58.57 57.92 58.82 59.68 60.22 60.29 60.06 59.44 59.08 59.47
Gross Operating Profit 202 192 184 180 176 172 174 176 189 204 221 241 244 245 247 245 247 248 243 236
Change (%) -4.74 -4.42 -1.84 -2.59 -2.12 1.19 1.33 6.96 8.40 8.06 8.91 1.53 0.17 1.01 -0.96 0.90 0.41 -1.81 -2.98
% of Revenue 45.36 45.32 44.58 43.62 43.00 41.78 41.81 40.63 40.99 41.32 41.43 42.08 41.18 40.32 39.78 39.71 39.94 40.56 40.92 40.53
SG&A 103 103 105 104 102 101 99 100 103 109 114 121 124 129 132 134 133 129 124 121
Change (%) -0.04 1.51 -0.52 -1.88 -1.40 -1.75 0.99 3.48 5.73 4.02 6.14 3.07 3.31 2.58 1.88 -1.17 -2.84 -4.01 -2.17
% of Revenue 23.19 24.31 25.40 25.18 25.01 24.48 23.78 23.04 22.48 22.10 21.34 21.12 20.98 21.19 21.23 21.80 21.47 21.10 20.81 20.79
R&D 13 13 13 12 10 9 9 9 11 13 14 17 17 17 20 18 17 21 21 21
Change (%) 0.61 -3.59 -5.60 -13.93 -12.94 6.23 -5.74 18.19 25.52 1.88 26.53 1.83 -0.75 17.80 -12.05 -2.25 18.72 1.10 -0.81
% of Revenue 2.92 3.09 3.06 2.88 2.51 2.17 2.28 2.06 2.30 2.68 2.53 2.99 2.93 2.85 3.27 2.90 2.83 3.40 3.53 3.57
OpEx 359 348 346 349 345 349 351 366 385 413 439 469 491 508 526 524 522 513 496 489
Change (%) -3.11 -0.70 1.02 -1.13 1.17 0.39 4.52 5.20 7.11 6.42 6.72 4.64 3.50 3.61 -0.46 -0.42 -1.62 -3.28 -1.57
% of Revenue 80.75 82.07 83.88 84.45 84.51 84.86 84.25 84.46 83.79 83.46 82.44 82.03 82.73 83.71 84.72 84.99 84.36 83.94 83.42 83.83
Operating Income 86 76 66 64 63 62 66 67 75 82 94 103 102 99 95 93 97 98 99 94
Change (%) -11.21 -12.60 -3.20 -1.64 -1.52 5.22 2.85 10.64 9.67 14.45 9.74 -0.32 -3.49 -3.97 -2.52 4.51 1.57 0.46 -4.47
% of Revenue 19.25 17.93 16.12 15.55 15.49 15.14 15.75 15.54 16.21 16.54 17.56 17.97 17.27 16.29 15.28 15.01 15.64 16.06 16.58 16.17
Interest Expense -0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -4 -5 -5 -5 -4 -4 -3 -3
Change (%) 153.85 45.58 16.13 0.90 -20.28 -13.37 11.90 -0.48 1.73 3.12 32.94 158.59 22.63 11.88 1.34 -28.35 -6.08 -1.57 -0.14
% of Revenue -0.07 -0.19 -0.28 -0.32 -0.33 -0.26 -0.22 -0.24 -0.23 -0.21 -0.20 -0.25 -0.63 -0.76 -0.83 -0.85 -0.60 -0.57 -0.58 -0.59
Net Income 72 64 56 51 50 49 51 53 59 65 75 83 81 80 78 78 82 84 85 82
Change (%) -11.49 -12.41 -8.73 -1.83 -1.57 4.60 2.89 11.28 10.28 14.90 10.96 -2.48 -1.15 -2.53 0.17 5.15 2.80 1.46 -3.94
% of Revenue 16.15 14.99 13.51 12.29 12.21 11.93 12.34 12.18 12.78 13.11 13.98 14.46 13.59 13.14 12.51 12.63 13.23 13.76 14.34 14.07

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista